The revelation of a patient death in Bristol Myers Squibb’s phase 3 trial of a potential pulmonary fibrosis treatment has ...

Roche Diagnostics has launched a new in vitro diagnostic test for newborn screening to detect a series of rare disorders.  | Roche Diagnostics has launched a new in vitro diagnostic test for newborn ...

A more subdued volume of biopharma layoffs continued into the third quarter of 2026, validating predictions that the sector ...

As Foghorn digested the end of the Lilly partnership, the biotech said it was laying off 40% of its workforce, while “further ...

When recombinant DNA expert Herbert Boyer, Ph.D., first got a call from venture capitalist Robert Swanson about starting a ...

Sanofi is paying Regeneron $1 billion upfront to collaborate on four early-stage im | Sanofi is paying Regeneron $1 billion ...

Eli Lilly has tied its amylin-Zepbound combination treatment eloraTZP to 23.3% average weight loss in patients struggling ...

Base editing biotech Beam Therapeutics is suing one of its newest rivals, alleging that the upstart company stole the secrets ...

Merck touted a win for its anti-TL1A antibody in a phase 2b trial in patients with moderate to severe hidradenitis ...

GSK is paying Wave Life Sciences $12 million upfront to take ownership of a hepatic program arising from the companies’ ...

Highlight Therapeutics touted positive topline results in patients with localized high-risk head and neck basal cell ...

Connect Biopharma has pointed to phase 2 data for its IL-4/IL-13 blocker as proof that the wannabe Dupixent rival can reduce ...